|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mittal S and El-Serag HB: Epidemiology of
hepatocellular carcinoma: Consider the population. J Clin
Gastroenterol. 47(Suppl): S2–S6. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lu T, Seto WK, Zhu RX, Lai CL and Yuen MF:
Prevention of hepatocellular carcinoma in chronic viral hepatitis B
and C infection. World J Gastroenterol. 19:8887–8894. 2013.
View Article : Google Scholar :
|
|
4
|
Zhu Z, Zhang X, Wang G and Zheng H: Role
of microRNAs in hepatocellular carcinoma. Hepat Mon. 14:e186722014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jang E, Kim BJ, Lee KT, Inn KS and Lee JH:
A survey of therapeutic effects of Artemisia capillaris in liver
diseases. Evid Based Complement Alternat Med. 2015:7281372015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mancuso A and Perricone G: Hepatocellular
carcinoma and liver transplantation: State of the art. J Clin
Transl Hepatol. 2:176–181. 2014. View Article : Google Scholar
|
|
7
|
Song IH: Cancer metastasis and metastasis
suppressors. Korean J. 43:1–7. 2004.
|
|
8
|
Stracke ML and Liotta LA: Multi-step
cascade of tumor cell metastasis. In Vivo. 6:309–316.
1992.PubMed/NCBI
|
|
9
|
Hu CT, Wu JR, Chang TY, Cheng CC and Wu
WS: The transcriptional factor Snail simultaneously triggers cell
cycle arrest and migration of human hepatoma HepG2. J Biomed Sci.
15:343–355. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huber MA, Kraut N and Beug H: Molecular
requirements for epithelial-mesenchymal transition during tumor
progression. Curr Opin Cell Biol. 17:548–558. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu XM, Yuan GJ, Li QW, Shan SL and Jiang
S: Hyperthermia inhibits transforming growth factor beta-induced
epithelial-mesenchymal transition (EMT) in HepG2 hepatocellular
carcinoma cells. Hepatogastroenterology. 59:2059–2063.
2012.PubMed/NCBI
|
|
12
|
Scanlon CS, Van Tubergen EA, Inglehart RC
and D'Silva NJ: Biomarkers of epithelial-mesenchymal transition in
squamous cell carcinoma. J Dent Res. 92:114–121. 2013. View Article : Google Scholar :
|
|
13
|
Shih JY and Yang PC: The EMT regulator
slug and lung carcinogenesis. Carcinogenesis. 32:1299–1304. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Szarvas T, vom Dorp F, Ergün S and Rübben
H: Matrix metalloproteinases and their clinical relevance in
urinary bladder cancer. Nat Rev Urol. 8:241–254. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sullivan NJ, Sasser AK, Axel AE, Vesuna F,
Raman V, Ramirez N, Oberyszyn TM and Hall BM: Interleukin-6 induces
an epithelial-mesenchymal transition phenotype in human breast
cancer cells. Oncogene. 28:2940–2947. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang L, Tian Z, Yang Q, Li H, Guan H, Shi
B, Hou P and Ji M: Sulforaphane inhibits thyroid cancer cell growth
and invasiveness through the reactive oxygen species-dependent
pathway. Oncotarget. 6:25917–25931. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu C, Shen G, Yuan X, Kim JH,
Gopalkrishnan A, Keum YS, Nair S and Kong AN: ERK and JNK signaling
pathways are involved in the regulation of activator protein 1 and
cell death elicited by three isothiocyanates in human prostate
cancer PC-3 cells. Carcinogenesis. 27:437–445. 2006. View Article : Google Scholar
|
|
19
|
Jackson SJ and Singletary KW:
Sulforaphane: A naturally occurring mammary carcinoma mitotic
inhibitor, which disrupts tubulin polymerization. Carcinogenesis.
25:219–227. 2004. View Article : Google Scholar
|
|
20
|
Bergantin E, Quarta C, Nanni C, Fanti S,
Pession A, Cantelli-Forti G, Tonelli R and Hrelia P: Sulforaphane
induces apoptosis in rhabdomyosarcoma and restores
TRAIL-sensitivity in the aggressive alveolar subtype leading to
tumor elimination in mice. Cancer Biol Ther. 15:1219–1225. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jeong WS, Kim IW, Hu R and Kong AN:
Modulatory properties of various natural chemopreventive agents on
the activation of NF-kappaB signaling pathway. Pharm Res.
21:661–670. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jeong WS, Kim IW, Hu R and Kong AN:
Modulation of AP-1 by natural chemopreventive compounds in human
colon HT-29 cancer cell line. Pharm Res. 21:649–660. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jo GH, Kim GY, Kim WJ, Park KY and Choi
YH: Sulforaphane induces apoptosis in T24 human urinary bladder
cancer cells through a reactive oxygen species-mediated
mitochondrial pathway: The involvement of endoplasmic reticulum
stress and the Nrf2 signaling pathway. Int J Oncol. 45:1497–1506.
2014.PubMed/NCBI
|
|
24
|
Park HS, Han MH, Kim GY, Moon SK, Kim WJ,
Hwang HJ, Park KY and Choi YH: Sulforaphane induces reactive oxygen
species-mediated mitotic arrest and subsequent apoptosis in human
bladder cancer 5637 cells. Food Chemical Toxicol. 64:157–165. 2014.
View Article : Google Scholar
|
|
25
|
Choi WY, Choi BT, Lee WH and Choi YH:
Sulforaphane generates reactive oxygen species leading to
mitochondrial perturbation for apoptosis in human leukemia U937
cells. Biomed Pharmacother. 62:637–644. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu WS, Tsai RK, Chang CH, Wang S, Wu JR
and Chang YX: Reactive oxygen species mediated sustained activation
of protein kinase C alpha and extracellular signal-regulated kinase
for migration of human hepatoma cell HepG2. Mol Cancer Res.
4:747–758. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shapiro TA, Fahey JW, Dinkova-Kostova AT,
Holtzclaw WD, Stephenson KK, Wade KL, Ye L and Talalay P: Safety,
tolerance, and metabolism of broccoli sprout glucosinolates and
isothiocyanates: A clinical phase I study. Nutr Cancer. 55:53–62.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Singh SV, Srivastava SK, Choi S, Lew KL,
Antosiewicz J, Xiao D, Zeng Y, Watkins SC, Johnson CS, Trump DL, et
al: Sulforaphane-induced cell death in human prostate cancer cells
is initiated by reactive oxygen species. J Biol Chem.
280:19911–19924. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim H, Kim EH, Eom YW, Kim WH, Kwon TK,
Lee SJ and Choi KS: Sulforaphane sensitizes tumor necrosis
factor-related apoptosis-inducing ligand (TRAIL)-resistant hepatoma
cells to TRAIL-induced apoptosis through reactive oxygen
species-mediated up-regulation of DR5. Cancer Res. 66:1740–1750.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fimognari C, Nüsse M, Cesari R, Iori R,
Cantelli-Forti G and Hrelia P: Growth inhibition, cell-cycle arrest
and apoptosis in human T-cell leukemia by the isothiocyanate
sulforaphane. Carcinogenesis. 23:581–586. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hamsa TP, Thejass P and Kuttan G:
Induction of apoptosis by sulforaphane in highly metastatic B16F-10
melanoma cells. Drug Chem Toxicol. 34:332–340. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rudolf E and Cervinka M: Sulforaphane
induces cytotoxicity and lysosome- and mitochondria-dependent cell
death in colon cancer cells with deleted p53. Toxicol In Vitro.
25:1302–1309. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Guarino M, Rubino B and Ballabio G: The
role of epithelial-mesenchymal transition in cancer pathology.
Pathology. 39:305–318. 2007. View Article : Google Scholar : PubMed/NCBI
|
